Trastuzumab−Polyethylenimine−Polyethylene Glycol Conjugates for Targeting Her2-Expressing Tumors
- 15 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 17 (5) , 1190-1199
- https://doi.org/10.1021/bc0601119
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Anti-GAD antibody targeted non-viral gene delivery to islet beta cellsJournal of Controlled Release, 2005
- PEGylation of Poly(ethylene imine) Affects Stability of Complexes with Plasmid DNA under in Vivo Conditions in a Dose-Dependent Manner after Intravenous Injection into MiceBioconjugate Chemistry, 2005
- Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesisThe Journal of Gene Medicine, 2004
- Galactose-PEI–DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiencyJournal of Controlled Release, 2003
- Targeted prodrug treatment of HER‐2‐positive breast tumor cells using trastuzumab and paclitaxel linked by A‐Z‐CINNTM LinkerJournal of Experimental Therapeutics and Oncology, 2003
- Side‐effects of a systemic injection of linear polyethylenimine–DNA complexesThe Journal of Gene Medicine, 2001
- Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic applicationGene Therapy, 2001
- Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI)The Journal of Gene Medicine, 1999
- PROGNOSTIC SIGNIFICANCE OF c‐erbB‐2 ONCOGENE IN AXILLARY NODE‐NEGATIVE BREAST CANCERAnz Journal of Surgery, 1996
- The new frontier: gene and oligonucleotide therapyPharmaceutica Acta Helvetiae, 1994